PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 54 filers reported holding PROQR THRAPEUTICS N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $490,772 | +27.5% | 377,517 | +58.9% | 0.15% | +36.4% |
| Q2 2023 | $384,778 | +0.7% | 237,517 | +32.4% | 0.11% | -8.5% |
| Q1 2023 | $381,981 | -37.4% | 179,334 | +8.7% | 0.12% | -36.4% |
| Q4 2022 | $610,500 | -11.9% | 165,000 | -82.3% | 0.18% | -30.8% |
| Q3 2022 | $693,000 | -4.3% | 931,400 | 0.0% | 0.27% | -15.6% |
| Q2 2022 | $724,000 | +782.9% | 931,400 | +924.6% | 0.32% | +854.5% |
| Q1 2022 | $82,000 | – | 90,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |